Scientific comment on tumor suppressor p53 protein expression: prognostic significance in patients with low-risk myelodysplastic syndrome

AUTOR(ES)

Velloso, Elvira Deolinda Rodrigues Pereira

FONTE

Rev. Bras. Hematol. Hemoter.

DATA DE PUBLICAÇÃO

2014-06

RESUMO

Documentos Relacionados

• Tumor suppressor p53 protein expression: prognostic significance in patients with low-risk myelodysplastic syndrome
• Utility of the p53 mutant protein in patients with low-risk myelodysplastic syndrome
• Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.
• Amphotericin B-related nephrotoxicity in low-risk patients
• Improving care of patients with low-risk differentiated thyroid carcinoma